Isis Pharmaceuticals, Inc. (ISIS) Posts Q2 Loss of 9c/Share

Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) reported Q2 EPS of ($0.09), $0.12 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $38.1 million versus the consensus estimate of $26.76 million.

For earnings history and earnings-related data on Isis Pharmaceuticals, Inc. (ISIS) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
• KB Home (KBH) PT Raised to $56 at Truist Securities
• Ecolab pops as Citi sees improving setup into Q2 earnings